Showing results (21-30 of 110) with videos related to
Sort By:
Pageof 11
Clinical Immunology (Orlando, Fla.)|March 4, 2023
JAK inhibition for CD3<sup>-</sup> CD4<sup>+</sup> lymphocytic-variant hypereosinophilic syndromeStanislas Faguer, Matthieu Groh, François Vergez, et al.Medicine|August 13, 2015
Reversible Severe Eosinophilic Endomyocardial Fibrosis During Pregnancy: A Case ReportMarc Pineton de Chambrun, Philippe Charron, Danièle Vauthier-Brouzes, et al.BMC Geriatrics|October 15, 2021
Persistent eosinopenia is associated with in-hospital mortality among older patients: unexpected prognostic value of a revisited biomarkerBethsabee Partouche, Marion Pepin, Pauline Mary de Farcy, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 1, 2019
Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature reviewAntoine Fayand, David Boutboul, Lionel Galicier, et al.Journal of Vascular Surgery|March 4, 2017
New insights on tuberculous aortitisLaure Delaval, Tiphaine Goulenok, Paul Achouh, et al.Journal of Proteome Research|February 10, 2011
Comparative proteomic analysis of blood eosinophils reveals redox signaling modifications in patients with FIP1L1-PDGFRA-associated chronic eosinophilic leukemiaJean-Emmanuel Kahn, Virginie Dutoit-Lefevre, Sophie Duban-Deweer, et al.Blood|January 6, 2011
Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patientsLaurent Arnaud, Guy Gorochov, Frédéric Charlotte, et al.International Journal of Stroke : Official Journal of the International Stroke Society|January 18, 2017
IRMA study: Prevalence of subdiaphragmatic visceral infarction in ischemic stroke and atrial fibrillationDavid Weisenburger-Lile, Delphine Lopez, Stephanie Russel, et al.Arthritis Care & Research|August 27, 2010
Tocilizumab in refractory adult Still's diseaseXavier Puéchal, Michel DeBandt, Jean-Marie Berthelot, et al.Rheumatology (Oxford, England)|November 28, 2013
Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patientsPierre Charles, Antoine Néel, Nathalie Tieulié, et al.Pageof 11